Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.078 | 0.7 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.7 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |